Biography and Research Information
OverviewAI-generated summary
Leah Brazil's research encompasses studies on cardiovascular function and risk factors, as well as cancer treatment and pharmacology. Brazil has co-authored publications on late-onset pericardial effusion and device extrusion following left atrial appendage occluder implantation, and on response-predictive biomarkers for lisavanbulin in patients with recurrent glioblastoma. Brazil collaborates with researchers including Subodh Devabhaktuni, Sai Nikhila Ghanta, Tushar Tarun, and Sandeep Randhawa, all from the University of Arkansas for Medical Sciences, with whom Brazil has shared publications. Brazil's work contributes to the understanding of specific medical conditions and potential treatment strategies.
Metrics
- Publications: 2
Selected Publications
-
Late-Onset Pericardial Effusion and Device Extrusion After Left Atrial Appendage Occluder Implantation (2025)
Collaboration Network
Top Collaborators
- 83P Evaluation of response-predictive biomarkers for lisavanbulin: A phase II study in patients with recurrent glioblastoma
- 83P Evaluation of response-predictive biomarkers for lisavanbulin: A phase II study in patients with recurrent glioblastoma
- 83P Evaluation of response-predictive biomarkers for lisavanbulin: A phase II study in patients with recurrent glioblastoma
- 83P Evaluation of response-predictive biomarkers for lisavanbulin: A phase II study in patients with recurrent glioblastoma
- 83P Evaluation of response-predictive biomarkers for lisavanbulin: A phase II study in patients with recurrent glioblastoma
- 83P Evaluation of response-predictive biomarkers for lisavanbulin: A phase II study in patients with recurrent glioblastoma
- 83P Evaluation of response-predictive biomarkers for lisavanbulin: A phase II study in patients with recurrent glioblastoma
- 83P Evaluation of response-predictive biomarkers for lisavanbulin: A phase II study in patients with recurrent glioblastoma
- 83P Evaluation of response-predictive biomarkers for lisavanbulin: A phase II study in patients with recurrent glioblastoma
- 83P Evaluation of response-predictive biomarkers for lisavanbulin: A phase II study in patients with recurrent glioblastoma
- 83P Evaluation of response-predictive biomarkers for lisavanbulin: A phase II study in patients with recurrent glioblastoma
- 83P Evaluation of response-predictive biomarkers for lisavanbulin: A phase II study in patients with recurrent glioblastoma
- 83P Evaluation of response-predictive biomarkers for lisavanbulin: A phase II study in patients with recurrent glioblastoma
- 83P Evaluation of response-predictive biomarkers for lisavanbulin: A phase II study in patients with recurrent glioblastoma
- 83P Evaluation of response-predictive biomarkers for lisavanbulin: A phase II study in patients with recurrent glioblastoma
Similar Researchers
Based on overlapping research topics